2017 Speakers and Panelists
- Linda Amper, PhD, President, Linda E Amper LLC
- Anjan Aralihalli, MBA, Venture Partner, CTI Life Sciences
- Sandipan Bagchi, Director, New Business Development, Fortress Biotech
- Hannah M. Bayer, PhD, Chief Scientist, The HUMAN Project
- Jodi B. Black, PhD, Deputy Director, National Institutes of Health – Office of Extramural Research
- Jeffrey M. Bockman, PhD, Senior Vice President, Oncology Practice Head, Defined Health
- Scott P. Bruder, MD, PhD, Founder and CEO, Bruder Consulting and Venture Group
- Faith L. Charles, Partner , Corporate Transactions and Securities Group and Chair, Life Sciences, Thompson Hine
- Hans Christinger, MS, MBA, VP, Business Development & Alliance Management, Ovid Therapeutics
- Ellen B. Corenswet, Senior Counsel, Covington & Burling LLP
- Vlad Coric, MD, Chief Executive Officer and Director, Biohaven Pharmaceuticals
- Sara Jane Demy, Founder & CEO, Demy-Colton
- Catarina R. Dolsten, Change Management Expert, Consultant and Executive Coach
- Peter Donnelly, MS, MBA, Managing Director, Accelerate NY Seed Fund
- Deborah Dunsire, MD, CEO and President, Xtuit Pharmaceuticals
- Joan Fallon, DC, Founder and CEO, Curemark
- Andrew Farquharson, Managing Director and Co-Founder, InCube Ventures
- James E. Flynn, Managing Partner, Deerfield
- Jonathan Garen, Chief Business Officer, uniQure
- Kaushik Ghosal, PhD, Director of Business Development, BioMotiv
- Harry Glorikian, MBA, General Partner, New Ventures Funds
- Colin Goddard, PhD, Chief Executive Officer, BlinkBio
- Stephen Goodman, JD, Co-Founder, Mid Atlantic Bio Angels; Partner, Pryor Cashman LLP
- Sherry Grisewood, CFA, Senior Investment Officer, FoxHill Asset Management
- Sonia Gulati, PhD, Assistant Director, New York Ventures
- Joseph V. Gulfo, MD, MBA, CEO, Breakthrough Medical Innovations, LLC
- Kenton C. Hasson, PhD, Senior Manager, Business Development & Innovation, Cannon BioMedical
- Timothy Hemesath, PhD, Director, External R&D Innovation, Site Lead New York Centers for Therapeutic Innovation, Pfizer In
- Dana C. Hilt, MD, Chief Medical Officer, Lysosomal Therapeutics Inc.
- Olivier Jarry, Senior Advisor, Columbia Capital
- Ginger S. Johnson, PhD, CEO, Defined Health
- Pavel Khrimian, Associate Director, Partnering and Strategy, MedImmune
- Kevin Koch, Venture Partner, Orbimed
- Wayne C. Koff, PhD, President and CEO, Human Vaccines Project
- Brian Korb, Managing Director, The Trout Group LLC
- Kristen Kosofsky, Senior Managing Director, Hercules Technology Capital
- Steven Kreit, CPA, Partner in Charge – NY Technology and Life Science Practice, EisnerAmper LLP
- Bart Kus, PhD, Associate Director, Partnering and Strategy (Business Development) MedImmune
- Elisabeth Leiderman, MD, Vice President, Corporate Development Fortress Biotech
- Keith Lenden, Venture Partner, ARCH Venture Partners
- Douglas W. Losordo, MD, FACC, FAHA, Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer, Caladrius Biosciences
- Sanford J. Madigan, PhD, Senior Vice President, COI Pharmaceuticals, Inc.
- Gene Mancino, Partner, Mancino Burfield Edgerton
- John M. McGill, PhD, Senior Director, LRL Science and Technology Partnerships, Lilly Research Laboratories, Eli Lilly and Company
- Christopher Mortko, PhD, Executive Director, Oncology Search & Evaluation Lead, Merck
- John Mumm, PhD, Director of Immunoncology R&D, MedImmune
- Sanjeev Munshi, Ph.D, MBA, Director, Business Development and Licensing, Merck
- Ilona Nemeth, Managing Parnter, Rumi Scientific
- C. David Nicholson, PhD, EVP & Chief R&D Officer, Allergan
- Bernard Peperstraete, MD, President and CEO, Acuamark Diagnostics, Inc.
- Sergei Petukhov, PhD, Partner, Enso Ventures
- Suresh M. Pitram, PhD, Advisor, External Innovation, Elanco Animal Health, a Division of Eli Lilly and Company
- William S. Podd President & Executive Director Landmark Angels and Landmark Family Office
- Alexander S. Preker, President & CEO, Health Investment & Financing Corporation
- Dennis J. Purcell, Founder and Senior Advisor, Aisling Capital LLC
- Kiran Reddy, MD, MBA, Venture Partner, Clarus Ventures
- Michael C Rice, MS, MBA, Principal, Defined Health
- John F. Resek, PhD, Partner, Carter, DeLuca, Farrell & Schmidt, LLP
- Alan S. Roemer, MBA, MPH, SVP, Corporate Development, Roivant Sciences, Inc.
- Issi Rozen, Chief Business Officer, Broad Institute of Harvard and MIT
- Charles S. Ryan, JD, PhD, President and Chief Executive Officer, Orthobond Corporation
- Ed Saltzman, Executive Chairman, Defined Health
- Joel S. Sandler, PhD, Associate Principal, Defined Health
- Joseph Scaduto, MS, MBA, Founder & CEO, Traverse Biosciences
- Barbara S. Schilberg, Managing Director and Chief Executive Officer, BioAdvance
- Ben Scruggs, PhD, Analyst, Hatteras Venture Partners
- Nimish Shah, MBA, Vice President, Venrock
- Bavani Shankar, MBA, Senior Director, Business Development, Scientific Partnering & Alliances, AstraZeneca
- Todd Sherer, PhD, Chief Executive Officer, Michael J. Fox Foundation for Parkinson’s Research
- Robert A. Silverman, Head, Externalized Drug Discovery Partnering, Roche
- Pinki Singh, Manager, Oncology Innovation, Eli Lilly and Company
- Kumar Srinivasan PhD, MBA, VP of Scientific Partnering and Alliance, AstraZeneca
- Barry Ticho, MD, PhD, Chief Medical Officer, Stoke Therapeutics, Inc.
- Robert Urban, PhD, Head, Johnson & Johnson Innovation
- Santhosh Vadivelu, PhD, President and Chief Executive Officer, EpiDestiny
- Samuel A. Waxman, Partner, Corporate Development, Paul Hastings
- Bob Williams, President, IVMatters
- Anton Xavier, MS, MBA, NY/NYC Biotech Scout, Targeted Therapeutics Discovery, Pfizer WRD
- Peter Young, Executive-in-Residence, Pappas Ventures
- Tingting Zhang-Kharas, PhD, Advisor – Oncology External Innovation, Eli Lilly and Company
- Alex Zisson, Managing Director, H.I.G. Capital
View a list of our 2016 speakers